ZCCHC2: A Protein with Multiple Roles in Cellular Processes (G54877)

Target Name: ZCCHC2

NCBI ID: G54877

ZCCHC2

ZCCHC2: A Protein with Multiple Roles in Cellular Processes

ZCCHC2 (FLJ20281) is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and liver. It is a member of the zebrafish homeobox gene family, which is a family of transcription factors that are involved in the regulation of gene expression. ZCCHC2 has been shown to play a role in the development and maintenance of various tissues, including the nervous system and organs.

One of the unique features of ZCCHC2 is its ability to form a complex with other proteins, including the transcription factor p53. This interaction between ZCCHC2 and p53 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

In addition to its role in cell signaling, ZCCHC2 has also been shown to be involved in the regulation of gene expression. This is because it contains several domains that are involved in the recognition and binding of DNA sequences. These domains include a N-terminal domain that is involved in the formation of a DNA-binding complex, as well as a C-terminal domain that is involved in the regulation of transcription factor activity.

One of the potential drug targets for ZCCHC2 is the inhibition of its activity. This can be achieved through a variety of methods, including the use of small molecules, antibodies, or RNA interference. For example, a small molecule called U012 has been shown to inhibit the activity of ZCCHC2, while an antibody has been shown to selectively bind to ZCCHC2 and prevent it from forming its DNA-binding complex with p53.

Another potential drug target for ZCCHC2 is its role in the development of various diseases, including cancer. ZCCHC2 has been shown to be involved in the regulation of cell proliferation, apoptosis, and angiogenesis, which are all processes that are involved in the development and progression of cancer. Therefore, inhibiting the activity of ZCCHC2 may be a potential strategy for the treatment of cancer.

In addition to its potential drug targets, ZCCHC2 also has potential as a biomarker for certain diseases. For example, ZCCHC2 has been shown to be involved in the regulation of cell death, which is a process that is involved in the diagnosis of certain diseases, such as neurodegenerative disorders. Therefore, the levels of ZCCHC2 in certain tissues, such as brain or heart, may be a potential biomarker for these diseases.

Overall, ZCCHC2 is a protein that has a variety of roles in the regulation of cellular processes, including cell growth, apoptosis, and inflammation. Its ability to form a complex with the transcription factor p53 and its role in the regulation of gene expression make it a potential drug target, as well as a potential biomarker for certain diseases. Further research is needed to fully understand the role of ZCCHC2 in these processes and its potential as a therapeutic agent.

Protein Name: Zinc Finger CCHC-type Containing 2

The "ZCCHC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZCCHC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets